St Jude Medical Inc (STJ)

80.30
NYSE : Health Care
Prev Close 79.90
Day Low/High 79.90 / 80.41
52 Wk Low/High 48.83 / 84.00
Avg Volume 2.34M
Exchange NYSE
Shares Outstanding 285.72M
Market Cap 22.83B
EPS 3.10
P/E Ratio 35.04
Div & Yield 1.24 (1.60%)

Latest News

Abbott Looks to Kill Alere Deal

Abbott Looks to Kill Alere Deal

The medical device giant files a suit against Alere in the Delaware Court of Chancery hoping to walk away from their $7.9 billion merger agreement.

The Most Admired Corporate Dealmakers in a Record Year

The Most Admired Corporate Dealmakers in a Record Year

In a record year for acquisitions, 18 companies from across the spectrum were singled out by M&A professionals for doing deals that got results.

HeartMate 3 Left-ventricular Assist System (Photo: Business Wire)

HeartMate 3 Left-ventricular Assist System (Photo: Business Wire)

St. Jude Medical, Inc.

European Union Regulators Said to Approve Abbott's St. Jude Acquisition

European Union Regulators Said to Approve Abbott's St. Jude Acquisition

European Union regulators are expected to approve Abbott Laboratories' $33 billion acquisition of St. Jude Medical.

Quadra Allure MP CRT-P (Photo: Business Wire)

Quadra Allure MP CRT-P (Photo: Business Wire)

St. Jude Medical, Inc.

The Internet of Things Is Transforming Healthcare, but There's One Huge Risk

The Internet of Things Is Transforming Healthcare, but There's One Huge Risk

Tech giants, Big Pharma and insurers are all angling to profit from the $3 trillion-plus U.S. healthcare market.

St. Jude Medical Shareholders Approve Merger With Abbott

St. Jude Medical Shareholders Approve Merger With Abbott

St. Jude Medical, Inc.

Boston Scientific Remains Disciplined Buyer in Light of Large-scale Industry Consolidation

Boston Scientific Remains Disciplined Buyer in Light of Large-scale Industry Consolidation

The medical devices company is likely to stick to small- to mid- sized M&A unless it finds itself the target.

St. Jude Medical Still a Buy Despite Product Concerns

St. Jude Medical Still a Buy Despite Product Concerns

St. Jude shares deserve to be higher ahead of the merger with Abbott Labs. Here's why.

Jim Cramer: Drug Stocks Feeling Political Pressure

Jim Cramer: Drug Stocks Feeling Political Pressure

Political pressure is weighing on drug and medical device stocks including Abbott Labs and St. Jude, says Jim Cramer.

Abbott CEO Is Unfazed by Muddy Waters' Attack on St. Jude

Abbott CEO Is Unfazed by Muddy Waters' Attack on St. Jude

Miles White also reiterated that Abbott Laboratories has no plans to divest of its diabetes business. He still believes in Alere over the long term.

St. Jude Spars With Muddy Waters After Earnings Miss

St. Jude Spars With Muddy Waters After Earnings Miss

The medical device maker responded to allegations that its devices could be hacked during its third quarter earnings call.

St. Jude Medical (STJ) Stock Slips, Q3 Earnings Miss Estimates

St. Jude Medical (STJ) Stock Slips, Q3 Earnings Miss Estimates

St. Jude Medical (STJ) reported earnings that fell short of Wall Street's projections on Wednesday.

St. Jude Medical Reports Third Quarter 2016 Results

St. Jude Medical Reports Third Quarter 2016 Results

St. Jude Medical, Inc.

Abbott, St. Jude Float Antitrust Spinoff by FTC

Abbott, St. Jude Float Antitrust Spinoff by FTC

They plan to sell portions of their vascular closure and electrophysiology businesses to Japan's Terumo Corp. for $1.12 billion.

St. Jude Medical And Abbott To Sell Portion Of Vascular Closure And Electrophysiology Businesses To Terumo Corporation

St. Jude Medical And Abbott To Sell Portion Of Vascular Closure And Electrophysiology Businesses To Terumo Corporation

- The agreement is an important step toward completion of Abbott's acquisition of St. Jude Medical

What to Look For When St. Jude Medical (STJ) Reports Q3 Earnings

What to Look For When St. Jude Medical (STJ) Reports Q3 Earnings

Analysts are expecting St. Jude Medical's (STJ) 2016 third-quarter earnings and revenue to rise year-over-year.

What to Watch on Wall Street This Week: Netflix Earnings, Fed Speakers

What to Watch on Wall Street This Week: Netflix Earnings, Fed Speakers

Investors will get a slew of earnings reports from major companies and a host of Federal Reserve speakers during the week of Oct. 17.

Illumina Leads Healthcare Selloff, Abbott and Zimmer Also Fall

Illumina Leads Healthcare Selloff, Abbott and Zimmer Also Fall

Illumina fell 24% on news that it was cutting revenue guidance.

Closing Bell: FCC Hits Comcast With Fine; U.S. Stocks Sell Off

Closing Bell: FCC Hits Comcast With Fine; U.S. Stocks Sell Off

U.S. stocks bottom out during Tuesday afternoon's session as a disappointing quarterly performance from Alcoa heralds a poor start to the third-quarter earnings season.